Story
Herbalife Options Market Prices in 24% Swing for Nov. 2 Earnings

Options traders are bracing for significant volatility in Herbalife Ltd. (HLF) shares, pricing in a potential 24% price swing following the company's upcoming earnings report on November 2. The nutritional products company is scheduled to release its results after the market close.
Volatility Priced In
The substantial expected move is derived from options market data compiled by Bloomberg. This figure, known as the options-implied move, reflects the market's collective expectation for the stock's price fluctuation, either up or down, after the results are announced. It serves as a key indicator of anticipated volatility rather than a directional forecast.
The high implied move suggests investors are anticipating potentially impactful news in the quarterly report, which could relate to sales figures, distributor trends, or forward guidance. Investors should be prepared for a potentially sharp price reaction following the announcement.
A History of Post-Earnings Swings
AdAn analysis of Herbalife's past earnings reactions shows a history of significant price action. The stock's actual post-earnings move has surpassed the options-implied move in four of the last eight reporting periods.
Notable past movements include:
- Feb. 19, 2025: A 53.1% surge, vastly exceeding the 11.4% implied move.
- May 6: A 12.9% decline, which was slightly larger than the 12.2% move priced in by options.
- Aug. 5 (most recent): An 8.2% drop, which was smaller than the 11.1% implied move.
This track record highlights the potential for significant volatility that can either meet, exceed, or fall short of market expectations, underscoring the uncertainty surrounding the company's quarterly disclosures.
Read next
More on Stocks
NVIDIA Stock Rallies on Strong AI Demand Signals from SpaceX, Morgan Stanley
Shares of the chipmaker gained over 3% following reports of a $40 billion GPU procurement plan by SpaceX and a bullish note from Morgan Stanley highlighting increased data center demand.

Nanobiotix Shares Rise on Positive Phase 1 Melanoma Trial Data
Nanobiotix (NASDAQ: NBTX) stock gained after the company reported promising final data from a Phase 1 trial of its cancer therapy, JNJ-1900, which showed a 41.7% overall response rate in patients with advanced, treatment-resistant melanoma.

Moroccan All Shares Index Edges Up 0.14% on Sector Strength
The Casablanca stock market closed slightly higher on Monday, with the benchmark Moroccan All Shares index gaining 0.14% amid strength in the banking and beverage sectors, despite a majority of stocks declining.

Petrobras CEO Dismisses Post-Election Stock Plunge as 'Speculative'
Petrobras CEO Magda Chambriard labeled the nearly 10% drop in the company's shares following President Lula's reelection as a 'speculative move,' asserting the state-run oil firm's fundamentals remain strong.